Cardiovascular risk: a class effect of coxibs? how to manage patients taking Vioxx?
Brune, K.; Zacher, J.
MMW Fortschritte der Medizin 146(42): 10; 12
2004
ISSN/ISBN: 1438-3276 PMID: 15536697 Document Number: 567203
Document emailed within 1 workday
Related Documents
Jerie, P. 2005: VIOXX written off--and what next? COX-2 inhibitors and cardiovascular diseases Casopis Lekaru Ceskych 144(1): 4Forejtová, S. 2006: Problems of cardiovascular toxicity of coxibs and non-selective NSA Vnitrni Lekarstvi 52(7-8): 677-685
Patrono, C. 2010: Cardiovascular effects of low-dose aspirin, traditional non-steroidal anti-inflammatory drugs and coxibs Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 165(1-2): 115-123; Discussion 124
Nossent, H. 2000: Risk of cardiovascular events and effect on mortality in patients with rheumatoid arthritis Journal of Rheumatology 27(9): 2282-2283
Hobbs, T.; Caso, R.; McMahon, D.; Nymark, M. 2014: A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study Alternative Therapies in Health and Medicine 20(5): 18-23
Wascher, T.C. 1998: Sulfonylureas and cardiovascular mortality in diabetes: a class effect? Circulation 97(14): 1427-1428
Toplak, H.; Sagmeister, E.; Wascher, T.C. 1994: Cardiovascular risk factors in obesity. the effect of weight reduction on platelet size in overweight patients International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 18(5): 355-356
Peredruk, T.V. 2013: Effect of cardiovascular risk factors on occurrence and course of silent form of ischemic heart disease in patients with postinfarction cardiosclerosis Likars'ka Sprava 3: 25-31
Oksa, A. 2006: Cardiovascular risk in patients with chronic kidney diseases: a time for new risk markers? Bratislavske Lekarske Listy 107(8): 314-319
Ametov, A.S.; Kochergina, I.I.; Ulanova, K.A. 2010: Effect of insulin therapy on insulin resistance and risk for ischemic heart disease and death from cardiovascular pathology in patients with diabetes mellitus, type 2 Terapevticheskii Arkhiv 82(3): 42-46
Kleber, M.E.; Winkler, K.; Wolfert, R.L.; Delgado, G. de Moissl; Grammer, T.B.; Dietz, S.; Winkelmann, B.R.; Boehm, B.O.; Winfried März 2011: Lipoprotein Associated Phospholipase A2 Concentration Predicts Total and Cardiovascular Mortality Independently of Established Risk Factors (The Ludwigshafen Risk and Cardiovascular Health Study) Clinical Laboratory 57(9-10): 659-667
Baena Díez, Jé.Miguel.; Del Val García, Jé.Luis.; Alemany Vilches, L.; Martínez Martínez, Jé.Luis.; Tomàs Pelegrina, J.; González Tejón, Ián.; Raidó Quintana, E.María.; Rovira España, Mónica. 2005: Risk of Suffering from Cardiovascular Diseases because of the Clustering of the Modifiable Cardiovascular Risk Factors in the Population Older than 15 years of a Health Care Center in Barcelona Revista espanola de salud publica 79: 365-378
Fellah, H.; Feki, M.; Feki, H.; Souissi, M.; Kaabachi, N.; Abdallah, T.B.; Massy, Z.A.; Maiz, H.B.; Lacour, B.; Mebazaa, A. 2004: Classical and "Non-classical" Cardiovascular Risk Factors in Tunisian Patients with End Stage Renal Disease: Prevalence and Association with Cardiovascular Events Clinical Laboratory 50(7-8): 447-453
Protopopova, D.; Masopust, J.; Maly, R.; Valis, M.; Bazant, J. 2012: The prevalence of cardiometabolic risk factors and the ten-year risk of fatal cardiovascular events in patients with schizophrenia and related psychotic disorders Psychiatria Danubina 24(3): 307-313
Osler, M.; Jespersen, N.B.; Lous, J.; Rasmussen, N.K. 1992: Cardiovascular risk factors--extent and self-assessed risk in relation to prevention of cardiovascular diseases. A questionnaire among 3,956 men and women aged 24-65 years in Vejle County, Slangerup and Helsinge municipalities Ugeskrift for Laeger 154(9): 538-543
Aghaeishahsavari, M.; Noroozianavval, M.; Veisi, P.; Parizad, R.; Samadikhah, J. 2006: Cardiovascular disease risk factors in patients with confirmed cardiovascular disease Saudi Medical Journal 27(9): 1358-1361
Homer, M.J. 1995: How to manage risk in breast screening Diagnostic Imaging 17(1): 25; 28-73
Schelp, M.; Holloway, L. 2015: Manage False Claims Risk Before It's Too Late! Missouri Medicine 112(6): 414-417
Hand, S.M. 1999: Edi helps IPAs, PHOs manage risk Healthcare Financial Management: Journal of the Healthcare Financial Management Association 53(2): 78-79; 81
Tungtrongchitr, R.; Pongpaew, P.; Phonrat, B.; Supawan, V.; Chanjanakitskul, S.; Vudhivai, N.; Schelp, F.Peter. 2002: The effect of cigarette smoking on ceruloplasmin and C3 complement: risk of cardiovascular disease (atherosclerosis) Asian Pacific Journal of Allergy and Immunology 20(1): 23-28